VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy.
about
Angiogenesis in Inflammatory Bowel DiseasePathophysiological role of guanylate-binding proteins in gastrointestinal diseasesAngiogenesis-related biomarkers in patients with alcoholic liver disease: their association with liver disease complications and outcome.The gut microbiota in mouse models of inflammatory bowel disease.Interferon Gamma Counteracts the Angiogenic Switch and Induces Vascular Permeability in Dextran Sulfate Sodium Colitis in Mice.The Gastrointestinal Circulation: Physiology and Pathophysiology.Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.Alpha-lipoic acid attenuates trinitrobenzene sulfonic acid-induced ulcerative colitis in mice.The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis.Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats.Colonic Insult Impairs Lymph Flow, Increases Cellular Content of the Lymph, Alters Local Lymphatic Microenvironment, and Leads to Sustained Inflammation in the Rat Ileum.Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases.Microangiopathy triggers, and inducible nitric oxide synthase exacerbates dextran sulfate sodium-induced colitis.
P2860
Q26769945-2B6E5C14-496A-43D2-9FF0-54C7A810F72DQ28078361-4619CD0C-C39D-4AC1-82D0-003CFA402844Q33736254-2F27076F-5841-4EDB-A856-E2B3F7EFD88FQ35117031-425D7786-CE9E-4F43-BD81-6078577D6C97Q35688870-4A41C1EC-E192-4DC0-A763-9871F9757B88Q38542463-61179E38-AF88-4B3D-87A0-ED85C01A650EQ39676371-FF3BC635-049D-46DB-8115-BAD138DAA5FAQ41199470-1B0A0C44-E0D2-49DF-B02E-AB2B9689F14FQ41770473-1D8C20BA-47CA-4873-A4CC-6EF9F8A6EE9CQ41901947-41ACE809-4662-4DEA-81F6-BC3A40AF6EEBQ42463498-9218B97C-3AB5-4D49-8E84-A2E5F66B5A99Q49971986-3CBEA688-28A6-4979-9B16-1916DD99E3B8Q52659719-CE43A7AD-5D74-4149-8C95-A21EC9D6CDF9
P2860
VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VEGF-A isoform modulation in a ...... effects of a VEGF164b therapy.
@en
VEGF-A isoform modulation in a ...... effects of a VEGF164b therapy.
@nl
type
label
VEGF-A isoform modulation in a ...... effects of a VEGF164b therapy.
@en
VEGF-A isoform modulation in a ...... effects of a VEGF164b therapy.
@nl
prefLabel
VEGF-A isoform modulation in a ...... effects of a VEGF164b therapy.
@en
VEGF-A isoform modulation in a ...... effects of a VEGF164b therapy.
@nl
P2093
P2860
P356
P1476
VEGF-A isoform modulation in a ...... effects of a VEGF164b therapy.
@en
P2093
Chaitanya V Ganta
J Michael Mathis
J Steven Alexander
James Traylor
Mihir Patel
Walter E Cromer
P2860
P2888
P356
10.1186/1479-5876-11-207
P50
P577
2013-09-11T00:00:00Z
P5875
P6179
1017912287